| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |